DiscoveRx is a product and technology based company offering proprietary biological read-out technologies for broad usage in the pharmaceutical and life sciences industries. The company’s objective is to develop and commercialize these technologies in the area of High Throughput Proteomics through innovative solutions that significantly reduce drug development time by addressing the bottlenecks of drug discovery. The benefits of our technologies include: speed of assay development; sensitivity; simplicity; and reliability.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 03/26/07 | Series C | 5M | Unknown |
People
Enal Razvi (VP Business Development)
Richard Eglan (Chief Scientific Officer)
Pyare Khanna (President/CEO/Founder)
Sailaja Kuchibhatla (SVP Business Development)
Paul Grayson (Board Member)
News
DiscoveRX raises $5M more for drug research technology
March 26, 2007 1:53 pm
DiscoveRx, a Fremont, Calif. company that offers biochemical and cell-based assays to make drug research more efficient, has raised $5… Continue reading ⟩